Scott Aaronson, MD

Harvard Medical School

McLean Hospital; Harvard University Health Services

Harvard Medical School - Sleep Physiology

• General Psychiatry
• Forensic Medicine

• Distinguished Fellow, American Psychiatric Association
• Member, American College of Psychiatrists
• Member, Maryland Psychiatric Society
• Member, Society of Biological Psychiatry
• Member, American College of Psychiatrists
• Member, American Society for Clinical Psychopharmacology
• Member, International Society of ECT and Neurostimulation
• Member, Clinical TMS Society

Garakani, Amir MD; Alexander, Jeanne L. MD; Sumner, Calvin R. MD; Pine, Janet H. MD; Gross, Lawrence S. MD; Raison, Charles L. MD; Aaronson, Scott T. MD; Baron, David A. DO. Psychedelics, With a Focus on Psilocybin: Issues for the Clinician. Journal of Psychiatric Practice 29(5):p 345-353, September 2023. DOI: 10.1097/PRA.0000000000000729

Sackheim, H.A., Aaronson, S.T., Bunker, M.T., Conway, C.R., Demitrack, M.A., George, M.S., Prudic, J., Thas, M.E., Rush, A.J. (2019). The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research, 113, 125–136.  doi: 10.1016/j.jpsychires.2019.03.021 

Scott T. Aaronson & Maria Mouratidis (2019) The Evolving Concept of a Therapeutic Community, Psychiatry, DOI: 10.1080/00332747.2019.1565557

Kumar, A., Bunker, M.T., Aaronson, S.T., Conway, C.R., Rothschild, A.J., Mordenti, G., Rush, A.J. (2019). Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression. Neuropsychiatric Disease and Treatment, Volume 15, 457–468. doi: 10.2147/ndt.s19666 

Rush, A.J., Aaronson, S.T., Demyttenaere, K. Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive, Aust N Z J Psychiatry. 2019 Feb;53(2):109-118. doi: 10.1177/0004867418808585. Epub 2018 Oct 31.

Aaronson ST, Conway CR. Vagus Nerve Stimulation: Changing the Paradigm for Chronic Severe Depression? Psychiatr Clin North Am. 2018 Sep;41(3):409-418. doi: 10.1016/j.psc.2018.05.001. Review. PubMed PMID: 30098654.

Conway CR, Kumar A, Xiong W, Bunker M, Aaronson ST, Rush AJ. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression. J Clin Psychiatry. 2018 Aug 21;79(5). pii: 18m12178. doi:10.4088/JCP.18m12178. PubMed PMID: 30152645

Martin DM, McClintock SM, Aaronson ST, Alonzo A, Husain MM, Lisanby SH,McDonald WM, Mohan A, Nikolin S, O'Reardon J, Weickert CS, Loo CK. Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trial. Brain Stimul. 2018 Aug 23. pii: S1935-861X(18)30294-8. doi:10.1016/j.brs.2018.08.011. [Epub ahead of print] PubMed PMID: 30172724.

Aaronson ST, Croarkin PE. Neurostimulation. In: Black DW, ed. Scientific American Psychiatry. Hamilton: Decker; July 2018. DOI: 10.2310/7800.13082. 

Aaronson ST, Philip NS. Neuromodulation. Psychiatr Clin North Am. 2018Sep;41(3):xiii-xvi. doi: 10.1016/j.psc.2018.06.001. Epub 2018 Jul 17. PubMed PMID: 30098663.

Kavanaugh BC, Aaronson ST, Clarke GN, Holtzheimer PE, Johnson CW, McDonald WM, Schneider MB, Carpenter LL. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation with a 2-Coil Device in Treatment-Resistant Major Depressive Disorder. J ECT. 2018 Apr 2. doi: 10.1097/YCT.0000000000000494. [Epub ahead of print] PubMed PMID: 29613944. 

Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T. Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial. JAMA Psychiatry. 2023 Dec 6. doi: 10.1001/jamapsychiatry.2023.4685. Epub ahead of print. PMID: 38055270.